Investigator Initiated Study to Assess the Safety of Combination of CLS-015 With Anti-CD-19 CAR-T Cells in Patients With Stable/Progressive Large B Cell Lymphoma at Lymphodepletion.
IsraelRecruitingPHASE1
Conditions
Large B-Cell Lymphoma (LBCL)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Sourasky Medical Center, Tel Aviv, Israel
Study leads
Ron Ram, Prof.
Principal Investigator
Sourasky Medical Center